Financial Snapshot
What does Align Technology’s latest financial snapshot show?
Mixed. The strongest factor is liquidity and revenue growth, while the main concern is weak cash conversion and average selling price pressure.
For Q1 2026, the verdict blends growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. Align Technology’s latest numbers show better sales momentum and positive earnings, but cash conversion remains a clear check on quality. For background on the company, see Align Technology, Inc. (ALGN): History, Ownership, Mission, How It Works & Makes Money.
Start with cash conversion, since it most directly tests whether Align Technology can turn revenue and earnings into durable financial flexibility.
Revenue and Earnings Quality
Does Align Technology’s revenue growth convert into quality earnings?
Strong. Q1 2026 growth looks supported by real demand because revenue rose with 6860K Clear Aligner cases and net income of $1128M, while diluted EPS reached $157. The main divergence is lower Clear Aligner Average Selling Price from lower-priced products and emerging markets.
Align Technology’s growth is more than a top-line bump: volume, profit, and EPS all improved in the same latest period. Investors still compare revenue durability with operating income, net income, and EPS across compatible annual periods because strong sales only count as quality earnings if they also convert into stable margins and per-share results.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $1040B, up 62%, Q1 2026 | $40B, FY 2025 | Volume-led, with lower Clear Aligner Average Selling Price from lower-priced products and emerging markets | Looks repeatable if volume keeps rising, but pricing pressure can trim quality |
| Operating Income | Not supplied for Q1 2026; FY 2025 Non-GAAP Operating Margin was 227% | FY 2025 Non-GAAP Operating Margin was 227% | Direction versus revenue is unavailable for Q1 2026 | Margin data can confirm operating leverage, but the latest quarter is incomplete here |
| Net Income | $1128M, Q1 2026 | $4104M, FY 2025 | Latest period shows profit, but the periods are not directly comparable | Positive earnings support quality, though annual comparison is not apples-to-apples |
| Diluted EPS | $157, Q1 2026 | $565, FY 2025 | Per-share earnings improved in the latest quarter | Shareholders saw earnings growth, not just revenue growth |
How durable is Align Technology’s revenue growth?
The strongest durability signal is 2995K worldwide doctor customers and 228M cumulative patients, plus double-digit Clear Aligner volume gains in EMEA, APAC, and Latin America. The biggest limitation is low patient traffic and orthodontic market stagnation, which hurt visibility.
- Demand Quality: Repeat volume is supported by 6860K Clear Aligner cases in Q1 2026, but orthodontic demand is still pressured by low patient traffic.
- Pricing and Volume: Verified volume is strong; the price-volume split is not fully disclosed, though lower-priced products and emerging markets reduced Average Selling Price.
- Diversification: Scale is broad across 2995K doctor customers, 228M patients, and double-digit volume growth in EMEA, APAC, and Latin America.
That mix points next to profitability and cash conversion. Mission Statement, Vision, & Core Values (2026) of Align Technology, Inc. (ALGN)
Margins and Cash Flow
Are Align Technology’s profits supported by cash flow?
Not fully yet. Align Technology’s margins are solid and management expects FY 2026 Non-GAAP Operating Margin guidance of 23.7%, but operating cash flow growth of -3232% and free cash flow growth of -5849% show weaker cash conversion than reported earnings.
Gross, operating, and net margins show how much of revenue stays after product costs, operating expenses, and taxes, while net income shows reported profit. For Align Technology, cash quality depends on whether operating cash flow and free cash flow rise with earnings after capital spending, and recent figures suggest that link is weaker than the margin profile alone implies.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | 70.8% in 2026-03-31 | Unavailable in supplied data | Pricing pressure from lower-priced product mix and emerging markets, partly offset by cost actions | Product economics remain supportive, but mix can pressure realized margin |
| Operating Margin | 16.6% in 2026-03-31 | Unavailable in supplied data | Management said cost-reduction actions drove a 250 basis point ex-FX improvement; FY 2026 guidance is 23.7% | Scale and cost control are helping operating efficiency |
| Net Margin | 10.8% in 2026-03-31 | Unavailable in supplied data | Operating income, interest expense of $000, and tax expense of $3612M | Final profitability is positive, but it is still below operating margin after taxes |
| Operating Cash Flow | Growth: -3232% | Previous period not supplied | Verified cash conversion weakness; working-capital timing may be a factor, but the input does not quantify it | Reported earnings are not translating cleanly into operating cash |
| Free Cash Flow | Growth: -5849% | Previous period not supplied | Capital expenditure burden is not supplied, so the source of the decline cannot be isolated | Less cash is left for reinvestment, buybacks, or debt reduction |
What most affects Align Technology’s cash conversion?
The biggest verified driver is weaker operating cash flow and free cash flow growth, even as management’s cost actions support margins. The gap suggests timing, working capital, or investment effects, not just core profitability.
- Main Driver: Cost-reduction actions are improving operating margin, but the cash slowdown looks temporary or timing-related rather than purely structural.
- Evidence Gap: The supplied data do not show working-capital details or capital expenditure, so the cash decline can’t be pinned to one cause.
- Metric to Monitor: Watch operating cash flow and free cash flow alongside the Exploring Align Technology, Inc. (ALGN) Investor Profile: Who's Buying and Why?
Liquidity Check
Does Align Technology have enough liquidity and balance sheet capacity to support its obligations and investment needs?
Strong. Align Technology’s cash, modest debt, and apparently manageable earnings burden give it good balance-sheet capacity. The main protection is $106B in cash and cash equivalents, while the main concern is that domestic cash is only $2066M, so cash location still matters.
Cash helps, but it is not the full story. For a clean balance-sheet read, investors should also look at working capital, asset quality, debt service, solvency, liquidity, and refinancing together. For more context, Exploring Align Technology, Inc. (ALGN) Investor Profile: Who's Buying and Why? helps connect the balance sheet to broader investor positioning.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash and cash equivalents: $106B as of March 31, 2026; domestic cash: $2066M; Receivables Growth: -280%; Inventory Growth: -504%. | Strong | Near-term obligations look covered, and liquidity appears available for operations and repurchases, though domestic cash is smaller than total cash. |
| Total and Net Debt | Total Debt: $8342M for 2026-03-31; Debt Growth: -2711%; net debt is not calculated here because only the supplied cash and debt figures should be used. | Strong | Leverage looks manageable relative to cash, so debt should not be a major constraint on flexibility right now. |
| Debt Service and Refinancing | Interest Expense: $000 from 2026-03-31; no maturity, covenant, or rate details were supplied; a $2000M 10b5-1 plan runs through October 2026. | Mixed | Current-period earnings support looks limited by the data, but there is no verified sign of immediate refinancing stress. |
| Asset Quality | Receivables Growth: -280% and Inventory Growth: -504% point to tighter operating-asset needs, not proof of demand strength. | Mixed | Asset efficiency may be improving, but investors should watch whether lower working assets reflect discipline or weaker activity. |
| Liabilities and Equity | Total liabilities and shareholders' equity were not supplied in the prompt, so book-capital coverage cannot be verified here. | Mixed | The capital base may be adequate, but the absence of verified equity data limits a full solvency read. |
Which balance-sheet risk matters most for Align Technology right now?
Working-capital direction is the main item to monitor. Receivables and inventory both fell sharply, which supports liquidity today, but investors should watch whether those trends stay disciplined or start to signal softer operating demand.
- Current Exposure: Cash and cash equivalents are $106B, while Total Debt is $8342M as of 2026-03-31.
- Protection: The strongest buffer is the cash position, plus the stated ability to support operations, expansion, and repurchases.
- Warning Signal: Watch whether domestic cash remains enough for U.S. needs and whether working capital trends keep weakening.
Capital Efficiency
Is Align Technology using capital efficiently while reinvesting?
Align Technology looks Mixed on capital efficiency. Internal cash appears sufficient for reinvestment needs right now, but returns are harder to judge without supplied ROIC, and buybacks support per-share results more than they prove strong operating reinvestment.
Return quality has to be read alongside leverage, asset intensity, capex, working capital, and outside funding needs. Align Technology’s positive Net Income of $11277M, rising book value per share, and repurchases matter, but so do R&D spending, manufacturing expansion, and whether cash generation stays strong enough to fund growth internally.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | unavailable | Operating margins and capital efficiency cannot be verified from the supplied figures alone. | Investors cannot confirm whether invested capital is creating operating value from the available data. |
| ROE and ROA | Positive Net Income: $11277M; Book Valueper Share Growth: 285%; Asset Growth: 129% | ROE may benefit from share repurchases and equity changes; ROA is pressured when assets grow faster than earnings. | Shareholder returns look supported, but leverage and asset buildup can flatter ROE while weakening asset efficiency. |
| Maintenance and Growth Investment | Research And Development Expenses: $9866M; Rdexpense Growth: 1881%; direct 3D printing progress, iTero Lumina Pro, Align X-ray Insights, Invisalign Specifix Attachment System, planned Hyderabad manufacturing facility | The spending mix points to meaningful growth investment, not just maintenance. | Align Technology appears to be funding product and capacity expansion to support future demand. |
| Internal Funding Capacity | FY 2025 total share repurchases of 29M shares for $4659M at an average price of $16209; new $2000M repurchase plan through October 2026 | Repurchases can support per-share metrics, but they do not prove higher operating returns; cash conversion and product mix remain important. | Internal funding appears supported by cash, though buybacks and reinvestment reduce flexibility if operating cash weakens. |
Are Align Technology's returns on capital sustainable?
Probably, but only if product mix and cash generation stay strong. The clearest durability source is growth in Invisalign-related and digital workflow products; the biggest weakness would be heavier reinvestment needs without matching operating cash flow, especially with ongoing buybacks.
- Operating Source: Product mix, R&D, and digital workflow gains from iTero Lumina Pro, Align X-ray Insights, and Invisalign Specifix Attachment System.
- Funding Requirement: The largest verified capital need is R&D, plus the planned Hyderabad manufacturing facility.
- Durability Test: Returns would weaken if asset growth keeps outpacing earnings or if cash conversion fails to fund both reinvestment and buybacks.
Financial Resilience
How resilient is Align Technology, and which warning signs matter most?
Resilience is Mixed. The main buffer is $106B in cash and cash equivalents plus reaffirmed FY 2026 Revenue Growth Guidance of 30% to 40%. The key warning sign is demand weakness, especially low U.S. patient traffic and stagnant orthodontic activity.
Align Technology can still fund operations and strategic investment, but resilience weakens if patients delay treatment, pricing stays under pressure, or cash generation slips. Active conversion efforts with financing partners help affordability, yet higher rates, inflation, and tariff-related reporting uncertainty can still squeeze liquidity and planning confidence.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Low patient traffic in the U.S. and orthodontic market stagnation can weaken operating leverage, reduce earnings quality, and limit cash flow support for debt capacity. Q1 2026 Clear Aligner Average Selling Price was also pressured by lower-priced products and emerging markets, even though ex-FX operating margin improved by 250 basis points. | Affordability programs, active conversion efforts with financing partners, cost-reduction actions, positive earnings, and reaffirmed FY 2026 Revenue Growth Guidance of 30% to 40%. | Watch for weaker revenue growth, further ASP compression, or margin erosion instead of the reported ex-FX improvement. |
| Working-Capital or Investment Pressure | Cash can be absorbed by receivables, inventory, capex, and R&D if sales become less predictable. The quarter ended March 31, 2026 also carried tariff-related reporting uncertainty, and management flagged possible Q2 2026 revenue impacts from ongoing military action in the Middle East. | Cash and cash equivalents of $106B support internal funding, and the company still has room to keep investing while demand stabilizes. | Monitor operating cash flow, free cash flow, and any sign that reporting volatility or revenue uncertainty is reducing internal funding. |
| Interest or Refinancing Pressure | High interest rates can raise the cost of refinancing and reduce flexibility if cash flow weakens. That matters less when leverage is limited, but it still affects future financing and investment decisions. | Limited latest debt evidence and a large cash balance reduce near-term refinancing stress. | Watch for rising debt, weaker interest coverage, or any need to borrow to fund normal operations. |
Which financial warning signs should investors monitor at Align Technology?
The strongest signals are weaker U.S. traffic and slower orthodontic demand, then ASP compression, and then cash conversion stress. Confirmed deterioration would show up in revenue or margin declines; future risk is tariff, rate, or Middle East-related disruption before it hits results.
U.S. Demand and Orthodontic Slowdown
Low patient traffic in the U.S. and orthodontic market stagnation can directly hit sales and operating leverage. Financing partner activity helps, but the next metric to watch is revenue growth by region and clear signs of weaker volume.
Clear Aligner Pricing Pressure
Q1 2026 Clear Aligner Average Selling Price was pressured by lower-priced products and emerging markets. That hurts margin quality unless cost cuts keep offsetting it, so investors should track gross margin and ex-FX operating margin.
Cash Conversion Volatility
Operating Cash Flow Growth: -3232% and Free Cash Flow Growth: -5849% point to sharp cash conversion weakness. The next metric is whether operating cash flow normalizes, because weak cash generation would limit investment flexibility.
Financial Health Scorecard
What does Align Technology’s financial health mean for investors?
Align Technology scores Mixed overall. The strongest factor is liquidity, while the weakest factor is cash conversion. The most important investment issue is whether strong operating momentum can keep turning into free cash flow.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | Q1 2026 revenue was $1040B, up 62%, with clear aligner volume at 6860K cases and diluted EPS of $157, showing strong growth and earnings leverage. |
| Profitability and Cash | Mixed | FY 2026 non-GAAP operating margin guidance of 237% supports profitability, but operating cash flow growth of -3232% and free cash flow growth of -5849% show weak cash conversion. |
| Balance Sheet and Liquidity | Strong | Cash and cash equivalents of $106B versus total debt of $8342M points to solid liquidity, manageable leverage, and room to absorb near-term pressure. |
| Capital Efficiency | Mixed | Repurchases can support per-share results, but ROIC, ROE, and ROA were not supplied, so capital efficiency is harder to judge from the available data. |
| Financial Resilience | Mixed | Cost actions and cash help, but pricing, demand, inflation, tariffs, and Middle East disruption remain pressure points that could hit margins or growth. |
- What Supports the Thesis: Strong revenue growth, rising case volume, and a net cash position create a durable operating base.
- What Challenges the Thesis: Earnings are not converting cleanly into cash, which raises execution and valuation risk.
- What to Monitor: Clear Aligner volume growth, Non-GAAP operating margin, and Free Cash Flow Growth.
For forecasts, scenarios, and valuation, the key question is whether Align Technology can keep scaling volume while protecting margins and converting profit into cash. If you’re using this for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help organize the evidence, and Mission Statement, Vision, & Core Values (2026) of Align Technology, Inc. (ALGN) adds useful strategic context.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
Why did Align’s operating margin improve despite pricing pressure?
Management cited cost-reduction actions, including a 250 basis point ex-FX improvement in operating margin This helped offset pressure from lower-priced product mix and emerging markets Investors should separate margin improvement from cash conversion because Operating Cash Flow Growth: -3232% remained weak
How much cash supports Align’s operating cushion?
Align reported Cash and Cash Equivalents: $106B as of March 31, 2026, with $2066M held domestically That supports operations, reinvestment, and repurchases, but domestic availability matters when comparing cash needs across regions
Does Align Technology carry meaningful debt pressure?
Latest enterprise value data shows Add Total Debt: $8342M for ALGN — 2026-03-31, while the income statement shows Interest Expense: $000 That suggests limited current pressure, but maturities, covenants, and refinancing terms are not provided
Are buybacks improving Align’s capital efficiency?
Buybacks may support per-share metrics because FY 2025 total share repurchases were 29M shares for $4659M at an average price of $16209 They do not automatically improve ROIC, ROE, or ROA without stronger operating returns and cash conversion
What risks could slow Align’s free cash generation?
The main risks are lower Clear Aligner ASP, weaker patient traffic, inflation, high interest rates, working-capital timing, and reinvestment needs Free Cash Flow Growth: -5849% already shows pressure, so investors should watch whether margin gains convert into cash